Teleflex acquires substantially all of BIOTRONIK Vascular Intervention business

The BIOTRONIK Vascular Intervention business, with the exception of IMDS products has been acquired by Teleflex, effective as of July 1st, 2025. These products are now part of the Teleflex portfolio. For questions or further information relating to the Vascular Intervention portfolio, please complete the contact form below.

Coronary Vascular Intervention

Coronary vascular intervention (CVI), also known as percutaneous coronary intervention (PCI) encompasses a variety of different minimally invasive percutaneous procedures used to treat Coronary Artery Disease (CAD). CAD is a condition in which the arteries inside the heart become narrowed or blocked usually due to the buildup of plaque. CVI aims to restore blood flow in these coronary arteries, relieve symptoms, and prevent complications.

9 products